Vertex Pharmaceuticals (VRTX) Intangibles (2009 - 2026)
Vertex Pharmaceuticals (VRTX) reported Intangibles of $412.8 million for Q2 2026, down 5.2% from $435.5 million a year earlier and down 1.4% from the prior quarter.
Vertex Pharmaceuticals (VRTX) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Vertex Pharmaceuticals posted Intangibles of $424.2 million, down 48.6% from FY2024.
- Intangibles has a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
- By year, Intangibles came in at $825.9 million in FY2024 (-1.7%), $839.9 million in FY2023 (+39.1%), $603.6 million in FY2022 (+50.9%) and $400 million in FY2021 (unchanged).
- The Q2 2026 figure ranks as the lowest quarterly Intangibles since Q2 2022.
- Year over year, Intangibles has now declined in each of the last seven quarters, with an average decline of 20.8% over the last eight quarters.
- The high point for year-over-year Intangibles in five years was Q2 2023 (growth of 56.0%); the low point was Q4 2025 (a decline of 48.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $418.5 million (Q1 2026), $424.2 million (Q4 2025) and $429.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 17.39 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 412.80 Mn |
| Mar 31, 2026 | 418.50 Mn |
| Dec 31, 2025 | 424.20 Mn |
| Sep 30, 2025 | 429.80 Mn |
| Jun 30, 2025 | 435.50 Mn |
| Mar 31, 2025 | 441.20 Mn |
| Dec 31, 2024 | 825.90 Mn |
| Sep 30, 2024 | 831.60 Mn |
| Jun 30, 2024 | 837.50 Mn |
| Mar 31, 2024 | 834.90 Mn |
| Dec 31, 2023 | 839.90 Mn |
| Sep 30, 2023 | 603.60 Mn |
| Jun 30, 2023 | 603.60 Mn |
| Mar 31, 2023 | 603.60 Mn |
| Dec 31, 2022 | 603.60 Mn |
| Sep 30, 2022 | 603.60 Mn |
| Jun 30, 2022 | 387.00 Mn |
| Mar 31, 2022 | 400.00 Mn |
| Dec 31, 2021 | 400.00 Mn |
| Sep 30, 2021 | 400.00 Mn |
Vertex Pharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=VRTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();